These effects could be partially inhibited with the tumour necrosis factor alpha (TNF-α) binding agent, etanercept, suggesting that TNF-α released from DEP-stimulated macrophages is an important regulator of DEP-induced endothelial dysfunction. Here, TNF is linked to endothelial dysfunction.